These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2337747)

  • 1. De-differentiation with time in prostate cancer and the influence of treatment on the course of the disease.
    Cumming JA; Ritchie AW; Goodman CM; McIntyre MA; Chisholm GD
    Br J Urol; 1990 Mar; 65(3):271-4. PubMed ID: 2337747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resection.
    Egevad L; Granfors T; Karlberg L; Bergh A; Stattin P
    J Urol; 2002 Aug; 168(2):509-13. PubMed ID: 12131299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group.
    Br J Urol; 1997 Feb; 79(2):235-46. PubMed ID: 9052476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental adenocarcinoma of the prostate: the role of repeat transurethral resection in staging.
    Sonda LP; Grossman HB; MacGregor RJ; Gikas PW
    Prostate; 1984; 5(2):141-6. PubMed ID: 6709517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of cancer progression in T1a prostate adenocarcinoma.
    Cheng L; Bergstralh EJ; Scherer BG; Neumann RM; Blute ML; Zincke H; Bostwick DG
    Cancer; 1999 Mar; 85(6):1300-4. PubMed ID: 10189135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can the need for palliative transurethral prostatic resection in patients with advanced carcinoma of the prostate be predicted?
    Sehgal A; Mandhani A; Gupta N; Dubey D; Srivastava A; Kapoor R; Kumar A
    J Endourol; 2005 Jun; 19(5):546-9. PubMed ID: 15989442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.
    Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
    Lancet Oncol; 2014 Sep; 15(10):1076-89. PubMed ID: 25130995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of transurethral resection on prognosis in carcinoma of the prostate: real or imaginary?
    McGowan DG
    Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1057-64. PubMed ID: 3182338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate Biopsy Specimens With Gleason 3+3=6 and Intraductal Carcinoma: Radical Prostatectomy Findings and Clinical Outcomes.
    Khani F; Epstein JI
    Am J Surg Pathol; 2015 Oct; 39(10):1383-9. PubMed ID: 26076065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transurethral prostatic resection for acute urinary retention in patients with prostate cancer.
    Chang CC; Kuo JY; Chen KK; Lin AT; Chang YH; Wu HH; Chang LS
    J Chin Med Assoc; 2006 Jan; 69(1):21-5. PubMed ID: 16447922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive accuracy of staging transurethral resection of the prostate in the management of stage A cancer of the prostate: a comparative evaluation.
    Lowe BA; Barry JM
    J Urol; 1990 Jun; 143(6):1142-5. PubMed ID: 2342175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation.
    Stromberg J; Martinez A; Benson R; Garton G; Diokno A; Gonzalez J; Zincke H; Schray M; Edmundson G; Brabbins D
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):67-75. PubMed ID: 8270460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transurethral resection versus needle biopsy prior to radical prostatectomy for stage C prostate cancer. Influence on progression and survival.
    Nativ O; Bergstralh EJ; Boyle ET; Zincke H
    Urology; 1991 Jan; 37(1):22-7. PubMed ID: 1986469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution and prognostic factors of adenocarcinomas of the prostate metastasizing at diagnosis].
    Arrizabalaga Moreno M; García González JI; Mora Durvan M; Díez Rodríguez JM; Esteban Artiaga R; Navarro Sebastián J; Castro Pita M; Paniagua Andrés P
    Actas Urol Esp; 1997 Sep; 21(8):724-36. PubMed ID: 9412221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management.
    Aydin H; Zhang J; Samaratunga H; Tan N; Magi-Galluzzi C; Klein E; Jones JS; Zhou M
    BJU Int; 2010 Feb; 105(4):476-80. PubMed ID: 19709071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer.
    Crain DS; Amling CL; Kane CJ
    J Urol; 2004 Feb; 171(2 Pt 1):668-71. PubMed ID: 14713783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of prostate stem cell antigen (PSCA) mRNA expression and subsequent prostate cancer risk in men with benign prostatic hyperplasia following transurethral resection of the prostate.
    Zhigang Z; Wenlu S
    Prostate; 2008 Feb; 68(2):190-9. PubMed ID: 18076024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative radiotherapy in 423 patients with pT3N0 prostate cancer.
    Petrovich Z; Lieskovsky G; Langholz B; Jozsef G; Streeter OE; Skinner DG
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):600-9. PubMed ID: 12062603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).
    Egevad L; Judge M; Delahunt B; Humphrey PA; Kristiansen G; Oxley J; Rasiah K; Takahashi H; Trpkov K; Varma M; Wheeler TM; Zhou M; Srigley JR; Kench JG
    Pathology; 2019 Jan; 51(1):11-20. PubMed ID: 30477882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up.
    Studer UE; Whelan P; Wimpissinger F; Casselman J; de Reijke TM; Knönagel H; Loidl W; Isorna S; Sundaram SK; Collette L;
    Eur Urol; 2014 Nov; 66(5):829-38. PubMed ID: 23932338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.